Parameter ALCAR group Placebo group
Number (%) of subjects with HIV-1 viral load <50 cc/ml 17 (81) 18 (86)
CD4 cell count (median increase per µl, IQR), 119 (67; 147) 161 (82;256)
MOS-HIV physical health score (median change, IQR) 0 (-2,1; 4.0) 0 (-0.9;0.8)
MOS-HIV mental score (median change, IQR) 0.7 (0;0.51) 0 (-2.1; 5.1)
EUROQOL visual analogue scale (median change, IQR) 0 (-1;15) 0 (0;13)
EUROQOL score (median change, IQR) 0 (0;0) 0 (0;0)
Number of subjects with lipodystrophy (%) 4 (22) 3 (16)
Table 3: Secondary endpoints at week 48. No endpoint reached statistical significance.
Goto home»